Using the ImmunoChip custom genotyping array, we analyzed 14,498 subjects with multiple
sclerosis and 24,091 healthy controls for 161,311 autosomal variants and identified 135 …

Multiple sclerosis is a chronic, often disabling, disease of the central nervous system affecting
more than 1 in 1,000 people in most western countries. The inflammatory lesions typical of …

Common risk factors for psychiatric and other brain disorders are likely to converge on biological
pathways influencing the development and maintenance of brain structure and function …

The human leukocyte antigen (HLA) haplotype DRB1*15:01 is the major risk factor for
multiple sclerosis (MS). Here, we find that DRB1*15:01 is hypomethylated and predominantly …

Multiple sclerosis (MS) is an inflammatory CNS disease with a substantial genetic component,
originally mapped to only the human leukocyte antigen (HLA) region. In the last 5 years, a …

Multiple sclerosis is a complex neurological disease, with ∼20% of risk heritability attributable
to common genetic variants, including >230 identified by genome-wide association …

Fatigue is a significant symptom in multiple sclerosis (MS) patients. First-generation disease
modifying therapies (DMTs) are at best moderately effective to improve fatigue. …

In a recent genome-wide association study (GWAS) based on 12 374 non-synonymous
single nucleotide polymorphisms we identified a number of candidate multiple sclerosis …

Background: Cortical atrophy is common in early relapsing–remitting multiple sclerosis (RRMS).
Whether this atrophy is caused by changes in cortical thickness or cortical surface area …

Objective: We investigated the association between 52 risk variants identified through
genome-wide association studies and disease severity in multiple sclerosis (MS). Methods: Ten …